Technical Analysis for ENTA - Enanta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 51.0 -2.05% -1.07
ENTA closed down 2.05 percent on Thursday, May 6, 2021, on 86 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical ENTA trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Earnings Movers Other 0.00%
20 DMA Support Bullish -2.05%
50 DMA Support Bullish -2.05%
180 Bullish Setup Bullish Swing Setup -2.05%
Cup with Handle Other -2.05%
Cup with Handle Other -0.80%
Inside Day Range Contraction -0.80%
Older End-of-Day Signals for ENTA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Support about 12 hours ago
20 DMA Support about 12 hours ago
Down 3% about 13 hours ago
Fell Below Previous Day's Low about 13 hours ago
Fell Below 50 DMA about 14 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Enanta Pharmaceuticals, Inc. Description

Enanta Pharmaceuticals, Inc., a biotechnology company, engages in the development of small molecule drugs for the infectious disease areas. Its product candidates include ABT-450, an inhibitor of NS3 protease that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV) infection; EDP-239, an NS5A Inhibitor for HCV infection; EDP-546, a Cyclophilin inhibitor, which is in preclinical studies for HCV infection treatment; and Nucleotide Polymerase inhibitor for HCV infection. The company also develops EDP-788, an intravenous drug for the treatment of methicillin-resistant Staphylococcus aureus bacteria. It has collaboration and license agreements with Novartis Institutes for BioMedical Research, Inc. and Abbott Laboratories. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Chemical Compounds Infection Viruses Medical Research Hepatitis C Infectious Disease Hepatitis C Virus HCV Pyrrolidines Staphylococcus Aureus Treatment Of Hepatitis Cyclophilin Cyclopropanes HCV Infection Methicillin

Is ENTA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 58.59
52 Week Low 40.32
Average Volume 125,850
200-Day Moving Average 47.54
50-Day Moving Average 50.62
20-Day Moving Average 50.84
10-Day Moving Average 51.15
Average True Range 1.94
ADX 13.46
+DI 20.09
-DI 17.27
Chandelier Exit (Long, 3 ATRs ) 47.94
Chandelier Exit (Short, 3 ATRs ) 53.62
Upper Bollinger Band 53.15
Lower Bollinger Band 48.54
Percent B (%b) 0.53
BandWidth 9.08
MACD Line 0.34
MACD Signal Line 0.27
MACD Histogram 0.0789
Fundamentals Value
Market Cap 1.02 Billion
Num Shares 20.1 Million
EPS 0.12
Price-to-Earnings (P/E) Ratio 428.57
Price-to-Sales 6.70
Price-to-Book 1.81
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 54.24
Resistance 3 (R3) 54.32 53.32 53.70
Resistance 2 (R2) 53.32 52.49 53.28 53.52
Resistance 1 (R1) 52.16 51.99 51.66 52.08 53.34
Pivot Point 51.16 51.16 50.91 51.12 51.16
Support 1 (S1) 50.00 50.33 49.50 49.92 48.66
Support 2 (S2) 49.00 49.83 48.96 48.48
Support 3 (S3) 47.84 49.00 48.30
Support 4 (S4) 47.76